Ravi Rajani an Honoree and Presenter at CX Symposium
Ravi Rajani, MD, was named the "Global Rising Star in Vascular Surgery" at the 40th Annual Charing Cross (CX) International Symposium in London, England. The CX Symposium is the longest running vascular and endovascular conference and exhibition for industry professionals in Europe.
Dr. Rajani also presented "Surveillance Recommendations Following TEVAR Should be Based on Initial Indication for Repair" at the event, which accumulated data on 203 patients that underwent thoracic endovascular aortic repair (TEVAR) at Emory University and Grady Memorial hospitals between July 1, 2011 through April 1, 2016.
For the study, Dr. Rajani's Emory Surgery faculty coauthors—Drs. Jaime Benarroch-Gampel, Bradley Leshnower, Guillermo Escobar, Yazan Duwayri, and William Jordan—were joined by then-medical student Richard Anthony Meena. Mr. Meena was mentored by Dr. Rajani during the discovery phase of his training, and is the first trainee to match into the Emory integrated vascular surgery residency that will begin in July 2018.
The investigation involved the evaluation of mid- and long-term TEVAR outcomes based on initial indication for repair, with the primary tracking component being the rate of compliance with contrast-enhanced CT scans as postoperative surveillance method.
Dr. Rajani and his team found that there were no differences in compliance score based on indication for repair, and the overall aorta-related complication rate was 34.6 percent. However, TEVAR for dissection was associated with increased long-term aorta-specific complications, leading the team to conclude that TEVAR for dissection should be subject to stricter surveillance guidelines than TEVAR for other indications.